Incyte Corporation (INCY)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 4,241,220 | 3,693,100 | 3,394,640 | 2,986,270 | 2,666,700 |
| Total assets | US$ in thousands | 5,444,320 | 6,782,110 | 5,840,980 | 4,933,350 | 3,560,920 |
| Total asset turnover | 0.78 | 0.54 | 0.58 | 0.61 | 0.75 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $4,241,220K ÷ $5,444,320K
= 0.78
Incyte Corporation's total asset turnover ratio has shown a downward trend over the past five years, decreasing from 0.75 in December 2020 to 0.78 in December 2024. This indicates that the company generated $0.78 in revenue for every $1 of assets in 2024. Although there was an increase in the ratio in 2024 compared to the prior years, the efficiency of utilizing its assets to generate revenue has been fluctuating. It is crucial for Incyte Corporation to continue monitoring and improving its asset utilization efficiency to ensure optimal financial performance.
Peer comparison
Dec 31, 2024
Company name
Symbol
Total asset turnover
Incyte Corporation
INCY
0.78
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Charles River Laboratories
CRL
0.55
Exelixis Inc
EXEL
0.74
IQVIA Holdings Inc
IQV
0.57
Medpace Holdings Inc
MEDP
1.00